23 Mar 2016 07:00
23 March 2016
OptiBiotix Health Plc
Notice of Results
Analyst Briefing
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its preliminary results for the year ended 30 November 2015 on Thursday 14 April 2016.
A briefing for analysts will take place in the Gresham room at the London Capital Club, 15 Abchurch Lane, London EC4N 7BW at 9.30am on Thursday 14 April 2016.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email optibiotix@walbrookpr.com.
For further information:
OptiBiotix Health plc | www.optibiotix.com |
Stephen O'Hara, Chief Executive | Contact via Walbrook below |
Cairn Financial Advisers LLP | Tel: 020 7148 7900 |
Liam Murray / Avi Robinson | |
Hybridan LLP (Joint Broker) Claire Louise Noyce | Tel: 020 3764 2341 |
Peterhouse Corporate Finance Ltd (Joint Broker) | Tel: 020 7469 0936 |
Duncan Vasey / Lucy Williams | |
Walbrook PR Ltd | Tel: 020 7933 8780 or optibiotix@walbrookpr.com |
Anna Dunphy | Mob: 07876 741 001 |
Mike Wort | Mob: 07900 608 002 |
OptiBiotix Health (OPTI)